Our mission is simple. Beat cancer to improve the lives of patients and their families.
ApeX Therapeutics is a biotechnology company focused on developing novel compounds to treat cancer. Our lead drug candidate – APX3330 – targets the treatment of pancreatic cancer and we expect to be in human clinical studies in 2016. Our experienced team of scientists and researchers is focused on getting there as fast as possible.